spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Ваксини - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
ibuprofen/codeine phosphate rockspring 400 mg/30 mg film - coated tablets
Майлан ЕООД - Ибупрофен, Кодеина фосфат полугидрат - 400 mg/30 mg film - coated tablets
holoclar
holostem s.r.l - ex vivo разширени автоложни епителни клетки на роговицата, съдържащи стволови клетки - stem cell transplantation; corneal diseases - Офталмологични - Лечение на възрастни пациенти с умерена до тежка лимбални стволови клетки дефицит (определени от наличието на повърхностни роговицата neovascularisation в най-малко две роговицата quadrants, с централен роговицата участие и тежко увредена зрителната острота), едностранни или двустранни, поради физическа или химическа очни Бърнс. За биопсия се изисква минимум 1-2 мм2 нечувствителен лимб.
dhc continus 60 mg modified - release tablets
mundipharma gesellschaft m.b.h. - Дигидрокодеин - 60 mg modified - release tablets
dhc continus 90 mg modified - release tablets
mundipharma gesellschaft m.b.h. - Дигидрокодеин - 90 mg modified - release tablets
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - Новообразувания На Простатата, Кастраци-Упорит - Терапевтични радиофармацевтици - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
nobilis ib ma5
intervet international b.v. - Вирус е инфекциозен бронхит (ibv); щам Ма5 - таблетка - ≥ 3,0 log 10 eid50 - пилета
solpadeine 500 mg/8 mg/30 mg soluble tablets
omega pharma limited - Парацетамол, Кофеин, Кодеин, - 500 mg/8 mg/30 mg soluble tablets
co-codamol 500/30 mg film - coated tablets
actavis group ptc ehf. - Парацетамол, Кодеина фосфат полугидрат - 500/30 mg film - coated tablets
co-codamol 1000/60 mg film - coated tablets
actavis group ptc ehf. - Парацетамол, Кодеина фосфат полугидрат - 1000/60 mg film - coated tablets